Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.

Saxena, Neeraj K

Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. [electronic resource] - Gastroenterology Nov 2010 - 1762-73, 1773.e1-5 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1528-0012

10.1053/j.gastro.2010.07.001 doi


Adiponectin--pharmacology
Animals
Apoptosis--drug effects
Blotting, Western
Carcinoma, Hepatocellular--metabolism
Cell Proliferation--drug effects
Disease Progression
Gene Expression Regulation, Neoplastic
Humans
JNK Mitogen-Activated Protein Kinases--metabolism
Liver Neoplasms, Experimental--metabolism
Mice
Mice, Nude
Neoplasm Transplantation
Phosphorylation--drug effects
RNA, Neoplasm--genetics
Receptors, Adiponectin--biosynthesis
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transplantation, Heterologous
Tumor Cells, Cultured